Elaine Sun

Elaine Sun

Director/Board Member at RECURSION PHARMACEUTICALS, INC.

Net worth: 83 252 $ as of 2026-05-30

55 year
Health Technology
Finance
Consumer Services

Profile

Elaine D. Sun occupies the position of Chief Financial Officer & Senior Vice President at Halozyme Therapeutics, Inc. Ms. Sun is also on the board of Cirius Therapeutics, Inc. In the past Ms. Sun was Chief Financial & Strategy Officer at Vaxcyte, Inc., Managing Director at Merrill Lynch & Co., Inc. and Managing Director at Evercore Capital Partners. She received an undergraduate degree from Wellesley College and an MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-20 23,190 ( 0% ) 83 252 $ 2026-05-30

Elaine Sun active positions

CompaniesPositionStart
RECURSION PHARMACEUTICALS, INC. Director/Board Member 2025-03-14
Director of Finance/CFO 2022-03-22
Director/Board Member 2023-01-04

Former positions of Elaine Sun

CompaniesPositionEnd
DYNAVAX TECHNOLOGIES CORPORATION Director/Board Member 2026-02-09
HALOZYME THERAPEUTICS, INC. Director of Finance/CFO 2022-02-01
VAXCYTE, INC. Director of Finance/CFO 2019-11-30
Founder -
Director/Board Member -
See the detail of Elaine Sun's experience

Training of Elaine Sun

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Technology Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!